These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 3325121

  • 21. [Guillain-Barré syndrome: from the original description to the modern concepts].
    Raphael JC, Sharshar T, Bourdain F, Léger JM.
    Ann Med Interne (Paris); 1999 Jan; 150(1):33-41. PubMed ID: 10093660
    [Abstract] [Full Text] [Related]

  • 22. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E, Turkay S, Icagasioglu D, Tanzer F, Cevit O.
    Turk J Pediatr; 1996 Jan; 38(1):119-23. PubMed ID: 8819632
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Guillain-Barré syndrome after bone marrow transplantation.
    Perry A, Mehta J, Iveson T, Treleaven J, Powles R.
    Bone Marrow Transplant; 1994 Jul; 14(1):165-7. PubMed ID: 7951108
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T, Nakagawa H, Uchiyama F, Fukuyama J.
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Polyuria during Guillain-Barré syndrome.
    Hantson P, De Coninck B, Horn JL, Ketelslegers JM, Mahieu P.
    Acta Neurol Belg; 1992 Jun; 92(2):77-82. PubMed ID: 1534958
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Guillain-Barré syndrome.
    Winer J.
    Br J Hosp Med; 1992 Jun; 51(6):313. PubMed ID: 8032572
    [No Abstract] [Full Text] [Related]

  • 32. Therapeutic problems in the management of Guillain-Barré syndrome.
    Bergamini L, Durelli L, Delsedime M, Cocito D.
    Acta Neurol (Napoli); 1984 Feb; 6(1):40-4. PubMed ID: 6711374
    [No Abstract] [Full Text] [Related]

  • 33. Do corticosteroids influence the disease course or mortality in Guillain-Barre' syndrome?
    Singh NK, Gupta A.
    J Assoc Physicians India; 1996 Jan; 44(1):22-4. PubMed ID: 8773088
    [Abstract] [Full Text] [Related]

  • 34. An approach to the care of patients with Guillain-Barré syndrome.
    Griswold K, Guanci MM, Ropper AH.
    Heart Lung; 1984 Jan; 13(1):66-72. PubMed ID: 6559188
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Guillain-Barré syndrome.
    James CM, Smith RW.
    J R Nav Med Serv; 1990 Jan; 76(1):56-7. PubMed ID: 2374111
    [No Abstract] [Full Text] [Related]

  • 38. Plasma exchange in Guillain-Barré syndrome and related disorders.
    Hughes RA.
    Transfus Sci; 1993 Jan; 14(1):3-8. PubMed ID: 10148308
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plasma exchange as a therapy for Guillain-Barré syndrome with immune complexes.
    Vox Sang; 1982 Jan; 43(4):231-2. PubMed ID: 6215766
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.